Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors

被引：0
|
作者：
Casalino, S. [1 ]
Gerdes, C. [2 ]
Saborowski, A. [2 ]
Quinzii, A. [1 ]
Zecchetto, C. [1 ]
Sordo, A. [3 ]
Messineo, L. [1 ]
Leta, L. C. [1 ]
Lucin, E. [1 ]
Mendo, L. [1 ]
Pietrobono, S. [1 ]
Vogel, A. [4 ]
Melisi, D. [1 ]
机构：
[1] Univ Verona, Digest Mol Clin Oncol Res Unit, Verona, Italy
[2] MHH, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[3] Univ Padua, Unit Biostat Epidemiol & Publ Hlth, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[4] Princess Margaret Canc Ctr, Div Gastroenterol & Hepatol, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.447
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304P
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [1] Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
    Graham, Rondell P.
    Fritcher, Emily G. Barr
    Pestova, Ekaterina
    Schulz, John
    Sitailo, Leonid A.
    Vasmatzis, George
    Murphy, Stephen J.
    McWilliams, Robert R.
    Hart, Steven N.
    Halling, Kevin C.
    Roberts, Lewis R.
    Gores, Gregory J.
    Couch, Fergus J.
    Zhang, Lizhi
    Borad, Mitesh J.
    Kipp, Benjamin R.
    HUMAN PATHOLOGY, 2014, 45 (08) : 1630 - 1638
  • [2] The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma
    Ruff, Samantha M.
    Roychowdhury, Sameek
    Pawlik, Timothy M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (07) : 779 - 788
  • [3] Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma
    Lamarca, Angela
    Ostios, Lorena
    Mcnamara, Mairead G.
    Garzon, Carlos
    Gleeson, Jack P.
    Edeline, Julien
    Herrero, Ana
    Hubner, Richard A.
    Moreno, Victor
    Valle, Juan W.
    CANCER TREATMENT REVIEWS, 2023, 121
  • [4] Fibroblast growth factor receptor (FGFR) inhibitor Treatment of intrahepatic cholangiocarcinoma
    Shaib, W. L.
    El-Rayes, B. F.
    DRUGS OF THE FUTURE, 2017, 42 (11) : 677 - 683
  • [5] Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma
    Kassaye, Isabell
    Alyafaie, Adam
    Zhang, Karen
    Lifton, Jacob
    Gordan, John D.
    Kelley, Robin Kate
    Yung, Madeline
    JAMA OPHTHALMOLOGY, 2024, 142 (12) : 1109 - 1113
  • [6] Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
    Raggi, Chiara
    Fiaccadori, Karim
    Pastore, Mirella
    Correnti, Margherita
    Piombanti, Benedetta
    Forti, Elisa
    Navari, Nadia
    Abbadessa, Giovanni
    Hall, Terence
    Destro, Annarita
    Di Tommaso, Luca
    Roncalli, Massimo
    Meng, Fanyin
    Glaser, Shannon
    Rovida, Elisabetta
    Peraldo-Neia, Caterina
    Olaizola, Paula
    Banales, Jesus M.
    Gerussi, Alessio
    Elvevi, Alessandra
    Busset, Michele Droz Dit
    Bhoori, Sherrie
    Mazzaferro, Vincenzo
    Alpini, Gianfranco
    Marra, Fabio
    Invernizzi, Pietro
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (10): : 2090 - 2101
  • [7] Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
    Tsujie, Masanori
    Iwai, Tomohisa
    Kubo, Shoji
    Ura, Takashi
    Hatano, Etsuro
    Sakai, Daisuke
    Takeda, Yutaka
    Kaibori, Masaki
    Kobayashi, Tomoe
    Katanuma, Akio
    Katayose, Yu
    Fukase, Koji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (06) : 911 - 917
  • [8] Targeted genomic profiling revealed a unique clinical phenotype in intrahepatic cholangiocarcinoma with fibroblast growth factor receptor rearrangement
    Zhu, Zhongzheng
    Dong, Hui
    Wu, Jianguo
    Dong, Wei
    Guo, Xianling
    Yu, Hua
    Fang, Juemin
    Gao, Song
    Chen, Xuejun
    Lu, Huangbin
    Cong, Wenming
    Xu, Qing
    TRANSLATIONAL ONCOLOGY, 2021, 14 (10):
  • [9] Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study
    Sasaki, Motoko
    Sato, Yasunori
    Nakanuma, Yasuni
    VIRCHOWS ARCHIV, 2024, 484 (06) : 915 - 923
  • [10] Diverse Landscape of Fibroblast Growth Factor Receptor 2 (FGFR2) Rearrangement Partners in Intrahepatic Cholangiocarcinoma (iCCA)
    Silverman, I. M.
    Reeser, J. W.
    Wing, M. R.
    Krook, M. A.
    Roychowdhury, S.
    Newton, R. C.
    Burn, T. C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1185 - 1185
12345